Xylazine, commonly known as “Tranq,” is an animal tranquilizer that is increasingly being found in the illegal drug supply, particularly in opioids like fentanyl and in cocaine. Its emergence is alarming health professionals and outreach workers due to its dangerous effects and the difficulty in treating overdoses.
The Growing Emergence of Tranq
Tranq first surged in areas of Puerto Rico and then in Philadelphia, where it was found in a staggering 91% of opioid samples in a recent period. In Massachusetts, data from January to mid-June shows that xylazine was present in 28% of drug samples tested. This infiltration into the drug supply is causing concern because xylazine is not approved for human use and is associated with a number of health risks.
The Dangers of Xylazine
Xylazine poses a significant danger due to its sedative properties, which can slow breathing, heart rate, and lower blood pressure. These effects are particularly hazardous when combined with opioids, as they can lead to an increased risk of overdose. Overdoses involving xylazine are also more complex to treat because Narcan, the medication commonly used to reverse opioid overdoses, is ineffective against xylazine sedation.
Moreover, the drug has been linked to severe wounds and infections among users, with some cases leading to amputations. Health providers are concerned about the “profound sedation” caused by xylazine, which can leave individuals unconscious for extended periods, making them vulnerable to injuries, environmental exposure, and assault.
Theodore Lee is the editor of Caveman Circus. He strives for self-improvement in all areas of his life, except his candy consumption, where he remains a champion gummy worm enthusiast. When not writing about mindfulness or living in integrity, you can find him hiding giant bags of sour patch kids under the bed.